IMPACT Trademark

Trademark Overview

On Tuesday, May 12, 2020, a trademark application was filed for IMPACT with the United States Patent and Trademark Office. The USPTO has given the IMPACT trademark a serial number of 88911640. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, December 5, 2024. This trademark is owned by The Leukemia & Lymphoma Society, Inc.. The IMPACT trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:

Charitable fundraising services; accepting and administering monetary charitable contributions; providing grants in the field of cancer research and treatment; providing grants in the field of clinical trials

Administration and management of research grants in the field of cancer

General Information

Serial Number88911640
Word MarkIMPACT
Filing DateTuesday, May 12, 2020
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, December 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2024

Trademark Statements

Goods and ServicesCharitable fundraising services; accepting and administering monetary charitable contributions; providing grants in the field of cancer research and treatment; providing grants in the field of clinical trials
Goods and ServicesAdministration and management of research grants in the field of cancer

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, May 22, 2020
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, May 22, 2020
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameThe Leukemia & Lymphoma Society, Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRye Brook, NY 10573

Trademark Events

Event DateEvent Description
Tuesday, June 30, 2020NON-FINAL ACTION E-MAILED
Friday, May 15, 2020NEW APPLICATION ENTERED
Friday, May 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 30, 2020ASSIGNED TO EXAMINER
Tuesday, June 30, 2020NON-FINAL ACTION WRITTEN
Tuesday, June 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, January 10, 2021SUSPENSION LETTER WRITTEN
Sunday, January 10, 2021LETTER OF SUSPENSION E-MAILED
Sunday, January 10, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, August 30, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, August 28, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, February 28, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, September 1, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, October 19, 2021ASSIGNED TO EXAMINER
Tuesday, March 1, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 27, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, August 26, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, August 26, 2024FINAL REFUSAL E-MAILED
Monday, August 26, 2024FINAL REFUSAL WRITTEN
Monday, November 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 25, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, December 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 18, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Related Keywords

impact field grants charitable providing cancer research treatment clinical management administration